bioRxiv Science⌕ Search

Biology subjects

Schürmann, M.

Publications and source records attributed to Schürmann, M..

2 recordsLinked to original sources

Graph-theoretic comparisons of structural covariance networks: quantifying the false discovery rate

Structural covariance networks (SCNs) represent spatial patterns of covariation in brain morphology, often as a network of connections between nodes representing correlations in grey matter volume or cortical thickness measured by magnetic resonance imaging (MRI). SCNs have been suggested to reveal differences in functional organisation that are reflected in coordinated alterations to brain structure, and often these differences are sought in graph-theoretic measures such as the degree of clustering, segregation into distinct modules, or the characteristic path length between nodes. A common practice is to calculate SCNs for groups of interest, and use permutation testing to determine if they are significantly different for the measure of interest. However, the statistical validity of group comparisons using SCN-derived graph measures remains poorly understood. Here, we systematically evaluate the reliability of SCN estimation and downstream graph-theoretic analyses using structural MRI data from the Human Connectome Project (n = 1,096). We use simulations to show the effects of sample size and atlas dimensionality on SCN reliability. Using bootstrapping to characterise the distribution of SCN graph measures, we establish that small sample sizes systematically bias graph-theoretic measures including clustering, characteristic path length and modularity. Finally, we use simulations based on extrema from the bootstrapping distribution to characterise the statistical power and false discovery rate (FDR) for graph-theoretic between-group comparisons of SCNs, showing that at small sample sizes (n [≤] 30) permutation testing is no better than chance. These findings suggest that many significant SCN group differences, particularly those using small samples and high-dimensional parcellations, may reflect sampling noise rather than true biological differences. We recommend that future SCN studies use larger samples, coarser parcellations, and explicitly evaluate reliability before interpreting group differences.

neuroscience↗

Patients with recurrent PVL+-Staphylococcus aureus infections show enhanced sensitivity to PVL-mediated formation of atypical NETs

Staphylococcus aureus (S. aureus) strains that produce the toxin Panton-Valentine leukocidin (PVL; PVL-SA) frequently cause recurrent skin and soft tissue infections (SSTI). PVL binds to and kills human neutrophils, resulting in the formation of neutrophil extracellular traps, but the pathomechanism has not been extensively studied. Furthermore, it is unclear why some individuals colonized with PVL-SA suffer from recurring infections whereas others are asymptomatic. We thus aimed to (a) investigate how PVL exerts its pathogenicity on neutrophils and (b) identify factors that could help to explain the predisposition of patients with recurring infections. We provide genetic and pharmacological evidence that PVL-induced NET formation is independent of NADPH-oxidase and reactive oxygen species (ROS) production. Moreover, through NET proteome analysis we identified that the protein content of PVL-induced NETs is different from NETs induced by mitogen or the microbial toxin nigericin. The abundance of the proteins cathelicidin (CAMP), elastase (NE), and proteinase 3 (PRTN3) was lower on PVL-induced NETs, and as such they were unable to kill S. aureus. Furthermore, we found that neutrophils from affected patients express higher levels of CD45, one of the PVL receptors, and are more susceptible to be killed at a low PVL concentration than control neutrophils. Neutrophils from patients that suffer from recurring PVL-positive infections may thus be more sensitive to PVL-induced NET formation, which might impair their ability to combat the infection. ImportanceIndividuals colonized by Staphylococcus aureus strains that produce Panton-Valentine leukocidin (PVL-SA) often present with recurrent skin and soft-tissue infections, whilst other individuals remain asymptomatic. PVL is a toxin that kills neutrophils, which results in the formation of neutrophil extracellular traps. Traps induced by other stimuli are known to be toxic to S. aureus. We found however that NETs specifically induced by PVL are not toxic to S. aureus. Furthermore, we show that neutrophils from individuals that suffer from recurring PVL-SA infections are more sensitive to PVL-induced NET formation compared to healthy individuals. The significance of our work is in identifying a mechanism through which PVL-SA may actively counter the engagement of neutrophils. Moreover, we identified that patients with recuring PVL-SA infections may be more sensitive to this mechanism, which may help to explain their clinical condition and might provide avenues for future treatment development.

immunology↗